US Scenario Modeling Hub, a collaborative modeling effort of 17 academic research institutions, reports a universal COVID-19 vaccination recommendation could avert thousands more US hospitalizations and deaths than a high-risk-only strategy.
COVID-19 remains a substantial current public health concern in the US, with higher in-hospital mortality than seasonal influenza during fall-winter 2023–2024.
The Advisory Committee on Immunization Practices (ACIP) sets vaccine use guidance and has traditionally been made up of medical and public health experts within the U.S. Centers for Disease Control and Prevention (CDC). The committee is tasked with framing evidence-based recommendations for the use of vaccines that are effective in controlling diseases.
Recently, the committee has undergone a complete turnover of members, removing seasoned experts in favor of political appointments that include a psychiatrist and several individuals that claim vaccines cause disease. Gone are family physicians and pediatric infectious disease specialists, epidemiologists, geriatric medicine specialists, obstetricians and anyone with experience as a public health implementer.
Scenario modeling offers a way to compare potential future outcomes of ACIP decisions and inform policy for public health groups that will no longer rely on ACIP recommendations.
In the study, “Scenario Projections of COVID-19 Burden in the US, 2024-2025,” published in JAMA Network Open, researchers used a decision-analytical model to project national hospitalizations and deaths from April 2024 to April 2025 and to assess the potential benefit of annual vaccine recommendations.
Nine independent teams produced projections under six scenarios that combined two immune escape rates, 20% and 50% per year. An immune escape rate is the annual reduction in protection against infection that occurs as new SARS-CoV-2 variants evolve. Projections covered the United States population of 332 million with an estimated 58 million aged 65 years.
Three vaccine recommendation strategies were tested. No recommendation, recommendation for high-risk groups only, or recommendation for all eligible individuals. Annually reformulated vaccines were assumed to match variants circulating on June 15, 2024, to be available on September 1, 2024, and to be 75% effective against hospitalization at the time of release.
Teams calibrated their models to weekly hospitalizations and deaths reported by the National Healthcare Safety Network and the National Center for Health Statistics.
In the worst case scenario, defined by high immune escape with no vaccine recommendation, projections reached 931,000 hospitalizations with a 95% projection interval of 0.5 to 1.3 million and 62,000 deaths with a 95% projection interval of 18,000 to 115,000.
In the best case defined by low immune escape with a universal recommendation, the ensemble projected 550,000 hospitalizations with a 95% projection interval of 296,000 to 832,000 and 42,000 deaths with a 95% projection interval of 13,000 to 72,000.
Severe outcomes clustered in older populations. Across scenarios, adults aged 65 years and older accounted for 51% to 62% of hospitalizations and 84% to 87% of deaths.
Vaccination of high-risk groups was only projected to avert 11% of hospitalizations under low immune escape and 8% under high escape, along with 13% and 10% of deaths. A universal recommendation increased the effect with 15% fewer hospitalizations under low immune escape and 11% fewer under high, with 16% and 13% fewer deaths.
Under high immune escape, a high-risk-only strategy averted 76,000 hospitalizations with a 95% CI of 34,000 to 118,000 and 7,000 deaths with a 95% CI of 3,000 to 11,000. Expanding to a universal recommendation prevented 104,000 hospitalizations with a 95% CI of 55,000 to 153,000 and 9,000 deaths with a 95% CI of 4,000 to 14,000.
Additional indirect benefits accrued to older adults under a universal strategy. Compared with high-risk-only vaccination, universal recommendations prevented about 11,000 more hospitalizations and 1,000 more deaths in those aged 65 years and older.
Observed national patterns diverged in timing from projections. A marked summer 2024 wave was followed by a smaller peak in January 2025, while projections anticipated the heaviest burden from late December 2024 to mid January 2025. Ensemble coverage for weekly deaths remained strong, with 95% intervals closely matching observed values.
Authors conclude that vaccines remain a critical tool to limit COVID-19 burden in 2024–2025, with universal recommendations offering added direct and indirect protection and the potential to save thousands more lives, including among older adults.
Written for you by our author Justin Jackson, edited by Sadie Harley, and fact-checked and reviewed by Robert Egan—this article is the result of careful human work. We rely on readers like you to keep independent science journalism alive. If this reporting matters to you, please consider a donation (especially monthly). You’ll get an ad-free account as a thank-you.
More information: Sara L. Loo et al, Scenario Projections of COVID-19 Burden in the US, 2024-2025, JAMA Network Open (2025). DOI: 10.1001/jamanetworkopen.2025.32469
News
Building the Brain Requires Millions of Dangerous DNA Breaks
Scientists discovered that building a healthy brain involves an unexpected step: young neurons routinely break and rapidly repair their own DNA. As the brain develops, newly formed nerve cells must travel through tightly packed tissue [...]
One Tiny Change May Explain How Viruses Jump From Bats to Humans
Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat. Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into [...]
Scientists Discover 250+ Genes That Could Lead to New Ways To Prevent Melanoma
The world’s largest study of mole genetics identified hundreds of genes tied to melanoma risk, uncovering potential new drug targets and paving the way for more accurate melanoma screening and prevention. Researchers at QIMR [...]
Breakthrough Diabetes Treatment Reprograms the Immune System
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, people with Type 1 diabetes have relied [...]
Taking the world’s temperature: WHO chief spotlights global health emergencies
Taking the world’s temperature on pressing health matters, WHO Director-General Tedros Adhanom Ghebreyesus provided the latest on current global challenges - and successes when it comes to international cooperation. “The outbreaks of hantavirus, Ebola and Marburg all show [...]
Scientists Create Tiny “Mini Livers” That Could One Day Replace Liver Transplants
Engineered tissue grafts could help perform key liver functions and benefit thousands of people living with liver failure. The liver is one of the body’s hardest-working organs, carrying out hundreds of vital jobs, from [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Scientists Discover Surprising Way To Help the Brain Recover After Stroke
A new study suggests that strengthening the body’s natural circadian rhythms may help the brain recover after stroke, even when treatment begins days after the injury. Every year, millions of people survive a stroke, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Younger Generations Are Aging Faster – and It May Be Fueling a Surge in Cancer
Younger generations may be aging biologically faster than those before them, and that shift could help explain rising rates of cancer at younger ages. For decades, cancer was viewed largely as a disease of [...]
Using Cannabis Could Raise Your Stroke Risk by 37%, Massive Study Reveals
Large-scale evidence suggests cannabis, cocaine, and amphetamines may directly raise stroke risk, including in younger adults. As recreational drug use becomes increasingly common, researchers are uncovering evidence that its health consequences may extend far beyond [...]
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
